MindMaze Therapeutics (SIX: MMTX)

Last close As at 20/03/2026

CHF0.41

−0.03 (−5.77%)

Market capitalisation

CHF69m

MindMaze Therapeutics (previously Relief Therapeutics) is a Swiss med-tech company advancing and commercialising a proprietary driven platform focused on neurotherapeutic solutions to treat neurological diseases (such as stroke and TBI), integrating software-based treatments with innovative technology, data and AI to improve patient outcomes.

Latest Insights

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Zach Henderson

    CEO

  • Jeremy Meinen

    CFO

  • Frédéric Condolo

    CTO

  • Paolo Galfetti

    CBO